BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 32058672)

  • 1. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
    Fairley JL; Hansen D; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Morrisroe K; Ferdowsi N; Major G; Roddy J; Stevens W; Nikpour M;
    Arthritis Care Res (Hoboken); 2021 May; 73(5):732-741. PubMed ID: 32058672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
    Chevalier K; Chassagnon G; Leonard-Louis S; Cohen P; Dunogue B; Regent A; Thoreau B; Mouthon L; Chaigne B
    J Autoimmun; 2024 Jun; 146():103220. PubMed ID: 38642508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.
    Reiseter S; Molberg Ø; Gunnarsson R; Lund MB; Aalokken TM; Aukrust P; Ueland T; Garen T; Brunborg C; Michelsen A; Abraityte A; Hoffmann-Vold AM
    Arthritis Res Ther; 2015 Aug; 17(1):231. PubMed ID: 26315510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients.
    Munteanu A; Kundnani NR; Caraba A
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1314-1326. PubMed ID: 38436165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleroderma overlap syndromes.
    Jablonska S; Blaszczyk M
    Adv Exp Med Biol; 1999; 455():85-92. PubMed ID: 10599327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease.
    Hoffmann-Vold AM; Gunnarsson R; Garen T; Midtvedt Ø; Molberg Ø
    J Rheumatol; 2015 Jan; 42(1):60-3. PubMed ID: 25274890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
    Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study.
    Batu ED; Günalp A; Şahin S; Özdel S; Kızıldağ Z; Pac Kısaarslan A; Bağrul İ; Kasap Cuceoglu M; Tanatar A; Sonmez HE; Sag E; Demir S; Çelikel E; Cağlayan S; Çelikel Acar B; Sözeri B; Aktay Ayaz N; Bilginer Y; Poyrazoğlu MH; Ünsal E; Kasapçopur Ö; Özen S
    Rheumatol Int; 2023 Aug; 43(8):1485-1495. PubMed ID: 36906866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic challenge of patients with anti-U1-RNP antibodies.
    Elhani I; Khoy K; Mariotte D; Comby E; Marcelli C; Le Mauff B; Audemard-Verger A; Boutemy J; Maigné G; Martin Silva N; Aouba A; de Boysson H
    Rheumatol Int; 2023 Mar; 43(3):509-521. PubMed ID: 35896805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
    J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study.
    Chaigne B; Chevalier K; Boucly A; Agard C; Baudet A; Bourdin A; Chabanne C; Cottin V; Fesler P; Goupil F; Jego P; Launay D; Lévesque H; Maurac A; Mohamed S; Tromeur C; Rottat L; Sitbon O; Humbert M; Mouthon L
    Rheumatology (Oxford); 2023 Oct; 62(10):3261-3267. PubMed ID: 36727465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
    Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
    Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
    Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL
    Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patients.
    Abouyahya I; Liem SIE; Amoura Z; Fonseca JE; Chaigne B; Cutolo M; Doria A; Fischer-Betz R; Guimaraes V; Huizinga TWJ; van Laar JM; Martin T; Matucci-Cerinic M; Montecucco C; Schneider M; Smith V; Müller-Ladner U; de Vries-Bouwstra JK
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):66-70. PubMed ID: 35579094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
    Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis.
    Wielosz E; Dryglewska M; Majdan M
    Ann Agric Environ Med; 2021 Mar; 28(1):189-192. PubMed ID: 33775087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint contractures responsive to immunosuppressive therapy in a girl with childhood-onset systemic sclerosis double-seropositive for rare anti-nucleolar autoantibodies: a case report.
    Tanaka R; Tani Y; Kaburaki Y; Kinoshita M; Kawaguchi Y; Okazaki Y; Kuwana M; Harigai M; Nagata S; Miyamae T
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):37. PubMed ID: 33743728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease.
    Cordiali-Fei P; Mussi A; D'Agosto G; Trento E; Bordignon V; Trincone S; Vento A; Sperduti I; Cristaudo A; Ensoli F
    Clin Dev Immunol; 2013; 2013():390563. PubMed ID: 23818915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.